Breast Cancer
Conference Coverage
Adding ACEI to Chemotherapy Does Not Prevent Cardiotoxicity
“We now have a definitive result in a robustly conducted trial that will take the field forward,” says an author of the new research.
Feature
What’s Driving the Higher Breast Cancer Death Rate in Black Women?
New research suggests that racial disparities in breast cancer are driven by more than socioeconomic factors.
From the Journals
Certain Women May Face Higher Risk for Second Breast Cancer
Two and a half percent of breast cancer survivors developed a second primary breast cancer, a new study shows.
From the Journals
Most Targeted Cancer Drugs Lack Substantial Clinical Benefit
Researchers assess validity of the molecular targets and clinical benefits of genome-targeted cancer drugs approved in the United States from 2015...
From the Journals
Is Axillary Surgery in Early Breast Cancer on Its Way Out?
Trial randomizes more than 2,000 patients to receive either axillary lymph node dissection or sentinel-node biopsy only.
Conference Coverage
How Medicare Reimbursement Trends Could Affect Breast Surgeries
A new study showed a decline in Medicare reimbursements for breast cancer surgery by more than 20% from 2003 to 2023.
Conference Coverage
No Routine Cancer Screening Option? New MCED Tests May Help
CanScan, MERCURY, and OncoSeek can detect a range of cancers and recognize the tissue of origin with high accuracy.
Feature
Do Real-World Data Support Omitting Sentinel Lymph Node Biopsy in Early Stage Breast Cancer?
No difference in outcomes seen in patients with early breast cancer and negative presurgery ultrasound who did or did not have sentinel lymph node...
From the Journals
Oncologists Voice Ethical Concerns Over AI in Cancer Care
Researchers ask 204 oncologists from 37 states for their views on the ethical implications of using AI for cancer care.
Conference Coverage
Circulating Tumor DNA Predicts Early Treatment Response in Patients With HER2-Positive Cancers
New study results suggest ctDNA dynamics provide an early window into predicting response to targeted therapies in patients with HER2-altered...
Conference Coverage
Repeat MCED Testing May ID Early-Stage and Unscreened Cancers
Eight of 26 patients with cancer signals detected through MCED had cancer.